These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37658449)

  • 1. Per- and polyfluoroalkyl substances, gestational weight gain, postpartum weight retention and body composition in the UPSIDE cohort.
    Kinkade CW; Rivera-Núñez Z; Thurston SW; Kannan K; Miller RK; Brunner J; Wong E; Groth S; O'Connor TG; Barrett ES
    Environ Health; 2023 Sep; 22(1):61. PubMed ID: 37658449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Per- and polyfluoroalkyl substance mixtures and gestational weight gain among mothers in the Health Outcomes and Measures of the Environment study.
    Romano ME; Gallagher LG; Eliot MN; Calafat AM; Chen A; Yolton K; Lanphear B; Braun JM
    Int J Hyg Environ Health; 2021 Jan; 231():113660. PubMed ID: 33181449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum concentrations of perfluoroalkyl substances during pregnancy and gestational weight gain: The Avon Longitudinal Study of Parents and Children.
    Marks KJ; Jeddy Z; Flanders WD; Northstone K; Fraser A; Calafat AM; Kato K; Hartman TJ
    Reprod Toxicol; 2019 Dec; 90():8-14. PubMed ID: 31415809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excessive gestational weight gain is associated with long-term body fat and weight retention at 7 y postpartum in African American and Dominican mothers with underweight, normal, and overweight prepregnancy BMI.
    Widen EM; Whyatt RM; Hoepner LA; Ramirez-Carvey J; Oberfield SE; Hassoun A; Perera FP; Gallagher D; Rundle AG
    Am J Clin Nutr; 2015 Dec; 102(6):1460-7. PubMed ID: 26490495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal Perfluorooctanoic Acid (PFOA) Exposure Is Associated With Lower Infant Birthweight Within the MADRES Pregnancy Cohort.
    Peterson AK; Eckel SP; Habre R; Yang T; Faham D; Farzan SF; Grubbs BH; Kannan K; Robinson M; Lerner D; Al-Marayati LA; Walker DK; Grant EG; Bastain TM; Breton CV
    Front Epidemiol; 2022; 2():934715. PubMed ID: 38455325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal perfluoroalkyl substances exposure and maternal sex steroid hormones across pregnancy.
    Rivera-Núñez Z; Kinkade CW; Khoury L; Brunner J; Murphy H; Wang C; Kannan K; Miller RK; O'Connor TG; Barrett ES
    Environ Res; 2023 Mar; 220():115233. PubMed ID: 36621543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Per- and Polyfluoroalkyl Substances (PFAS) Mixture during Pregnancy and Postpartum Weight Retention in the New Hampshire Birth Cohort Study (NHBCS).
    Wang Y; Howe C; Gallagher LG; Botelho JC; Calafat AM; Karagas MR; Romano ME
    Toxics; 2023 May; 11(5):. PubMed ID: 37235264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of Prenatal Per- and Polyfluoroalkyl Substance (PFAS) Exposures with Offspring Adiposity and Body Composition at 16-20 Years of Age: Project Viva.
    Zhang M; Rifas-Shiman SL; Aris IM; Fleisch AF; Lin PD; Nichols AR; Oken E; Hivert MF
    Environ Health Perspect; 2023 Dec; 131(12):127002. PubMed ID: 38054701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth Outcomes in Relation to Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Stress in the Environmental Influences on Child Health Outcomes (ECHO) Program.
    Padula AM; Ning X; Bakre S; Barrett ES; Bastain T; Bennett DH; Bloom MS; Breton CV; Dunlop AL; Eick SM; Ferrara A; Fleisch A; Geiger S; Goin DE; Kannan K; Karagas MR; Korrick S; Meeker JD; Morello-Frosch R; O'Connor TG; Oken E; Robinson M; Romano ME; Schantz SL; Schmidt RJ; Starling AP; Zhu Y; Hamra GB; Woodruff TJ;
    Environ Health Perspect; 2023 Mar; 131(3):37006. PubMed ID: 36920051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal Plasma Perfluoroalkyl Substances and Miscarriage: A Nested Case-Control Study in the Danish National Birth Cohort.
    Liew Z; Luo J; Nohr EA; Bech BH; Bossi R; Arah OA; Olsen J
    Environ Health Perspect; 2020 Apr; 128(4):47007. PubMed ID: 32319790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotoxicity assessment of per- and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
    Ojo AF; Peng C; Ng JC
    Toxicology; 2022 Dec; 482():153359. PubMed ID: 36341878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational perfluoroalkyl substance exposure and body mass index trajectories over the first 12 years of life.
    Braun JM; Eliot M; Papandonatos GD; Buckley JP; Cecil KM; Kalkwarf HJ; Chen A; Eaton CB; Kelsey K; Lanphear BP; Yolton K
    Int J Obes (Lond); 2021 Jan; 45(1):25-35. PubMed ID: 33208860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of perfluoroalkyl substances (PFAS) and body composition - A cross-sectional study in a middle-aged population.
    Lind PM; Lind L; Salihovic S; Ahlström H; Michaelsson K; Kullberg J; Strand R
    Environ Res; 2022 Jun; 209():112677. PubMed ID: 35074350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of perfluoroalkyl substance concentrations in pregnant women by socio-demographic and dietary factors in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Martinez D; Ibarluzea J; Santa-Marina L; Schettgen T; Vioque J; Sunyer J; Vrijheid M
    Environ Int; 2016; 92-93():357-65. PubMed ID: 27132161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of per- and polyfluoroalkyl substances with maternal early second trimester sex-steroid hormones.
    Pacyga DC; Papandonatos GD; Rosas L; Whalen J; Smith S; Park JS; Gardiner JC; Braun JM; Schantz SL; Strakovsky RS
    Int J Hyg Environ Health; 2024 Jun; 259():114380. PubMed ID: 38657330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal exposure to per- and polyfluoroalkyl substances and infant growth and adiposity: the Healthy Start Study.
    Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Dabelea D
    Environ Int; 2019 Oct; 131():104983. PubMed ID: 31284113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
    Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
    Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.